Non-Current Assets
Deferred Tax Assets
Biogen Deferred Tax Assets decreased by 18.6% to $238.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 22.5%, from $307.50M to $238.20M. Over 5 years (FY 2020 to FY 2025), Deferred Tax Assets shows a downward trend with a -26.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ4 2019
Last reportedQ1 2026
How to read this metric
An increase may indicate past operating losses or tax credits that provide a future buffer, while a decrease suggests the utilization of these benefits to offset tax liabilities.
Detailed definition
This represents the future tax benefits that the company expects to realize due to temporary differences between the fin...
Peer comparison
Standard across all industries; levels depend heavily on the company's historical profitability and tax jurisdiction profile.
Metric ID:
non_current_assets_deferred_income_tax_assets_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.85B | $1.81B | $1.42B | $1.29B | $1.24B | $1.17B | $1.23B | $1.21B | $1.21B | $1.07B | $928.60M | $898.30M | $915.10M | $968.70M | $324.20M | $307.50M | $330.90M | $312.40M | $292.50M | $238.20M |
| QoQ Change | — | -2.1% | -21.8% | -8.9% | -4.1% | -5.0% | +4.4% | -1.2% | -0.3% | -11.5% | -13.2% | -3.3% | +1.9% | +5.9% | -66.5% | -5.2% | +7.6% | -5.6% | -6.4% | -18.6% |
| YoY Change | — | — | — | — | -33.2% | -35.1% | -13.3% | -6.0% | -2.2% | -8.9% | -24.3% | -25.9% | -24.3% | -9.5% | -65.1% | -65.8% | -63.8% | -67.8% | -9.8% | -22.5% |
Range$238.20M – $1.85B
CAGR-35.0%
Avg YoY Growth-29.8%
Median YoY Growth-24.3%
Current Streak3 quarters decline
Deferred Tax Assets at Other Companies
Frequently Asked Questions
- What is Biogen's deferred tax assets?
- Biogen (BIIB) reported deferred tax assets of $238.20M in Q1 2026.
- How has Biogen's deferred tax assets changed year-over-year?
- Biogen's deferred tax assets decreased by 22.5% year-over-year, from $307.50M to $238.20M.
- What is the long-term trend for Biogen's deferred tax assets?
- Over 5 years (2020 to 2025), Biogen's deferred tax assets has grown at a -26.6% compound annual growth rate (CAGR), from $1.37B to $292.50M.
- What does deferred tax assets mean?
- Future tax savings the company expects to realize based on past financial activities.